In our screen (which was based on neuroblastoma and hepatoma cells), we found two other neuroendocrine factors, (1) glucocorticoids and (2) thyroid hormone, that negatively affected the cellular content of ACBP/DBI, although due to rather distinct mechanisms. Here, TG is linked to neuroblastoma.